SPC Life Sciences gets Sebi's go ahead to float IPOSPC Life Sciences has received approval from the Securities and Exchange Board of India (Sebi) to raise funds through an initial public off...
03 Jul, 2023, 01.27 PM IST
Lupin launches generic medication in US marketDrug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company's product, in strengths o...
22 Feb, 2023, 08.03 AM IST
Natco Pharma gets green nod for Rs 480 crore expansion projectNatco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.
21 May, 2017, 12.35 PM IST
Aurobindo gains on USFDA final nod for anti-psychotic tabletsShares of Aurobindo Pharma climbed five per cent today as the company has received final approval from the US health regulator FDA to manuf...
09 Oct, 2015, 07.30 PM IST
Torrent recalls anti-psychotic tablet from US marketTorrent Pharma Inc, a US subsidiary of Ahmedabad-based Torrent Pharma is recalling anti-psychotic drug Olanzapine 10 mg tablets from the US...
09 Aug, 2013, 04.57 AM IST
- Cadila stock touches 52 week high after gettting USFDA approval for two generic drugs
According to pharma analyst, the company would continue to witness jump in its stock prices as it is bullish on getting FDA approval for it...
12 Sep, 2012, 12.05 AM IST
Wockhardt gets tentative USFDA nod for anti-psychotic drugPharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psycho...
22 Aug, 2012, 04.34 PM IST
- Zydus Cadila gets USFDA nod for schizophrenia drug
The company got a tentative approval for aripiprazole orally disintegrating tabs in the strengths of 10 mg, 15 mg, 20 mg and 30 mg.
31 Jul, 2012, 06.49 PM IST
Price control of patented drugs may hit MNCs like Pfizer, GlaxoSmithKline hard: AnalystsThe government's decision to cap prices of patented drugs may hit the multinational pharma companies like Pfizer, GlaxoSmithKline and Merck...
29 Jul, 2012, 03.07 PM IST
- Surya Pharma launches neuropsychiatric division
The Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN .
01 Nov, 2011, 10.48 PM IST
- AstraZeneca Q3 net profit down 27 per cent
AstraZeneca PLC has reported a 27 per cent drop in third-quarter profit as it took nearly half a billion dollars in charges for product lia...
28 Oct, 2010, 12.51 PM IST
- Aussie nod for Ranbaxy's anti-psychotic drug
Ranbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag's anti-schizop...
26 Mar, 2009, 02.45 AM IST
- Bristol-Myers to shut half of its plants in 3 years
Apart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...
07 Dec, 2007, 01.11 AM IST
- Lupin receives USFDA nod for anti-psychotic drug
Domestic pharma company Lupin Ltd on Monday said it has received tentative approval from the US Food and Drug Administration (USFDA) for it...
21 May, 2007, 02.30 PM IST
- Pharma cos see future in chronic medicines
Increase in health awareness, affluent lifestyle and disposable income is expected to propel the Indian chronic drug segment to double its ...
09 Apr, 2007, 01.36 AM IST
- Cos see future in chronic drugs
Increase in health awareness, affluent lifestyle and disposable income is expected to propel the Indian chronic drug segment to double its ...
05 Apr, 2007, 02.17 AM IST
- Mankind to venture into anti-psychotics
Mankind Pharma, which registered the highest growth in the industry over the last one year, is venturing into the Rs 1,000-crore anti-psych...
04 Apr, 2007, 01.36 AM IST